Erich A. Peterson, Ph.D.
Affiliations: | 2012 | Computer Science | University of Arkansas at Little Rock, USA |
Area:
Computer ScienceGoogle:
"Erich Peterson"Parents
Sign in to add mentor| Peiyi Tang | grad student | 2012 | University of Arkansas at Little Rock | |
| (New algorithms for frequent sequential pattern and itemset data mining in certain and uncertain databases.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Ashby C, Rutherford M, Bauer MA, et al. (2020) TarPan: an easily adaptable targeted sequencing panel viewer for research and clinical use. Bmc Bioinformatics. 21: 144 |
| Johann DJ, Laun S, Stephens O, et al. (2020) Utilizing single-cell-subtype analysis via advanced microdissection methods and the impact on precision medicine. Journal of Clinical Oncology. 38: e15571-e15571 |
| Chavan SS, He J, Tytarenko R, et al. (2017) Bi-allelic inactivation is more prevalent at relapse in multiple myeloma, identifying RB1 as an independent prognostic marker. Blood Cancer Journal. 7: e535 |
| Weinhold N, Ashby C, Rasche L, et al. (2016) Clonal selection and double hit events involving tumor suppressor genes underlie relapse from chemotherapy: myeloma as a model. Blood |
| Chavan SS, Heuck C, He J, et al. (2016) High Risk Myeloma Is Characterized By the Bi-Allelic Inactivation of CDKN2C and RB1 Blood. 128: 4416-4416 |
| Peterson EA, Bauer MA, Chavan SS, et al. (2015) Enhancing cancer clonality analysis with integrative genomics. Bmc Bioinformatics. 16: S7 |
| Heuck C, Weinhold N, Peterson EA, et al. (2015) The Impact of Combination Chemotherapy and Tandem Stem Cell Transplant on Clonal Substructure and Mutational Pattern at Relapse of MM Blood. 126: 372-372 |
| Melchor L, Jones JR, Lenive O, et al. (2015) Spatiotemporal Analysis of Intraclonal Heterogeneity in Multiple Myeloma: Unravelling the Impact of Treatment and the Propagating Capacity of Subclones Using Whole Exome Sequencing Blood. 126: 371-371 |
| Heuck C, Chavan SS, Stein CK, et al. (2015) Comprehensive Genomic Profiling of Multiple Myeloma in the Course of Clinical Care Identifies Targetable and Prognostically Significant Genomic Alterations Blood. 126: 369-369 |
| Weinhold N, Chavan SS, Heuck C, et al. (2015) High Risk Multiple Myeloma Demonstrates Marked Spatial Genomic Heterogeneity Between Focal Lesions and Random Bone Marrow; Implications for Targeted Therapy and Treatment Resistance Blood. 126: 20-20 |